MC1930A1 - Produit antiviral - Google Patents

Produit antiviral

Info

Publication number
MC1930A1
MC1930A1 MC87EP8700417D MC1930D MC1930A1 MC 1930 A1 MC1930 A1 MC 1930A1 MC 87EP8700417 D MC87EP8700417 D MC 87EP8700417D MC 1930 D MC1930 D MC 1930D MC 1930 A1 MC1930 A1 MC 1930A1
Authority
MC
Monaco
Prior art keywords
pct
sec
viruses
date
sulphonamide derivatives
Prior art date
Application number
MC87EP8700417D
Other languages
English (en)
Inventor
Komp Bernd
Kresken Joachim
Stockhausen Dolf
Original Assignee
Stockhausen Chem Fab Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stockhausen Chem Fab Gmbh filed Critical Stockhausen Chem Fab Gmbh
Publication of MC1930A1 publication Critical patent/MC1930A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MC87EP8700417D 1986-08-02 1987-07-30 Produit antiviral MC1930A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863626309 DE3626309A1 (de) 1986-08-02 1986-08-02 Antivirusmittel
PCT/EP1987/000417 WO1988000828A1 (fr) 1986-08-02 1987-07-30 Agent antiviral

Publications (1)

Publication Number Publication Date
MC1930A1 true MC1930A1 (fr) 1989-05-19

Family

ID=6306629

Family Applications (1)

Application Number Title Priority Date Filing Date
MC87EP8700417D MC1930A1 (fr) 1986-08-02 1987-07-30 Produit antiviral

Country Status (9)

Country Link
US (1) US5026690A (fr)
EP (1) EP0315638B1 (fr)
JP (1) JP2622534B2 (fr)
AT (1) ATE59778T1 (fr)
AU (1) AU613874B2 (fr)
DE (2) DE3626309A1 (fr)
DK (1) DK178188D0 (fr)
MC (1) MC1930A1 (fr)
WO (1) WO1988000828A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670144A (en) * 1990-07-09 1997-09-23 Merrell Pharmaceuticals Inc. Anti-herpes virus and cytomegalovirus polyester oligomers
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
DE69106493T2 (de) * 1991-02-05 1995-06-29 Merrell Dow Pharma Sulfonische Stilbenderivate zur Behandlung von Viruserkrankungen.
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
ES2115756T3 (es) * 1992-02-20 1998-07-01 Merrell Pharma Inc Derivados de acido sulfonico utilizados en el tratamiento de enfermedades virales.
DE4229713B4 (de) * 1992-09-05 2005-06-23 Schiller, Friedrich, Prof. Dr.med.habil. Lippencreme
IL112174A (en) * 1994-01-03 1999-05-09 Merrell Dow Pharma Oligomers of polythioureas pharmaceutical compositions containing them and a process for their preparation
ES2191292T3 (es) * 1997-04-10 2003-09-01 Upjohn Co Compuestos antivirales poliaromaticos.
DE19919793A1 (de) * 1999-04-30 2000-11-02 Bayer Ag Neue Sulfonamide
GB2367242B (en) * 2000-09-21 2004-07-28 Henderson Morley Res & Dev Ltd Antiviral treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH362688A (de) * 1957-09-10 1962-06-30 Geigy Ag J R Verfahren zur Herstellung von neuen Arylsulfonarylamiden
DE2433723B2 (de) * 1974-07-13 1976-11-25 Sulfonamidderivate, verfahren zu ihrer herstellung und ihre verwendung
US4034110A (en) * 1976-09-20 1977-07-05 Hoffmann-La Roche Inc. Anthelmintics effective against liver flukes
NZ215272A (en) * 1985-02-27 1989-08-29 Mitsui Toatsu Chemicals Fungicidal n-(2-chloro-4-nitrophenyl)-benzenesulphonamide derivatives and compositions thereof

Also Published As

Publication number Publication date
DK178188A (da) 1988-03-30
DE3626309A1 (de) 1988-02-18
AU7806187A (en) 1988-02-24
EP0315638B1 (fr) 1991-01-09
DE3767308D1 (de) 1991-02-14
WO1988000828A1 (fr) 1988-02-11
EP0315638A1 (fr) 1989-05-17
ATE59778T1 (de) 1991-01-15
US5026690A (en) 1991-06-25
JP2622534B2 (ja) 1997-06-18
DK178188D0 (da) 1988-03-30
AU613874B2 (en) 1991-08-15
JPH01503457A (ja) 1989-11-22

Similar Documents

Publication Publication Date Title
JPS6470457A (en) Local remedy for skin damaged by beam
EA199901031A1 (ru) Производные бензимидазола
ES554967A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
DK0973735T3 (da) Polyaromatiske antivirale præparater
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
ZA862289B (en) Application of azolylmethyloxiranes for the treatmazolylmethyloxiranes,their preparation and their uent of viral diseases se as crop protection agents
GR3023825T3 (en) Benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
FI903153A0 (fi) 11b-aryl-4-estrener, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel.
ATE175873T1 (de) Weitere indolderivate mit antiviraler wirkung
DE3173954D1 (en) Use of adenosin derivatives for the manufacture of psychopharmacons
NL960024I1 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus gesmette patiënten.
MX13270A (es) Procedimiento para la preparacion de derivados de 4-aminopiridina
MC1930A1 (fr) Produit antiviral
SE503436C2 (sv) Pyroglutamidderivat
ZA879280B (en) Basically substituted phenylacetonitriles,their preparation and drugs containing these compounds
FI902901A0 (fi) Dibenzol/1,5/dioxocin-5-one-derivat, deras anvaendning i laekemedel och foerfarande foer deras framstaellning.
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
EP0716856A3 (fr) Utilisations thérapeutiques de dérivés du 2',5'-oligoadenylate
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
WO1991015200A3 (fr) Utilisation trinitrobenzenes ou d'acide carminique pour le traitement du cancer ou de maladies virales
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
IT1213034B (it) Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.

Legal Events

Date Code Title Description
YP Annual fee paid
YP Annual fee paid